How PPAR Agonists Help Reduce Inflammation
Author Information
Author(s): Wan Yu-Jui Yvonne, Badr Mostafa Z.
Primary Institution: The University of Kansas Medical Center
Hypothesis
The absence of hepatocyte-specific RXRα interferes with the ability of PPAR agonists to control inflammation.
Conclusion
Hepatocyte-specific RXRα is crucial for the anti-inflammatory effects of PPAR agonists.
Supporting Evidence
- PPAR agonists significantly reduced inflammation in wild-type mice.
- The antiedema effect was absent in RXRα-deficient mice.
- Aspirin reduced inflammation equally in both wild-type and RXRα-deficient mice.
Takeaway
This study found that a specific receptor in the liver helps certain drugs reduce swelling and inflammation.
Methodology
The study used wild-type and hepatocyte-specific RXRα-deficient mice to evaluate the effects of PPAR agonists on carrageenan-induced paw edema.
Limitations
The study primarily focused on a specific receptor in a specific cell type, which may limit the generalizability of the findings.
Participant Demographics
Male mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website